Analyst
Molecule Ventures
Equibles does not estimate personal net worth.
Grisha Kansara is recorded as Analyst at Molecule Ventures. Grisha Kansara has spoken on 3 earnings calls across 2 companies, most recently for Shilpa Medicare Limited on August 5, 2026. Those appearances were for Shilpa Medicare Limited and Happy Forgings Limited. The companies whose calls Grisha Kansara spoke on are classified in the Healthcare and Industrials sectors.
“Firstly, many congratulations to the entire team on a very good set of numbers. Firstly, on Nord UDCA, I have three questions. First, post our launch in Q3 of FY26, we have seen two quarters of commercial revenue, and our domestic formulation segment has contributed 59 crores in these two quarters.”
“So, sir, firstly, congratulations on a very good set of numbers. My question is that in one of the previous calls, when our order book was around 800 crores, you had provided a detailed... Order book breakup between different end-user industries.”
“So, first of all, congratulations on a very good set of numbers. The first question is quickly on the P&L side. The share of profit of 18 crores from associates and JVs which we have reported in this quarter.”
Molecule Ventures
Analyst
Transcript header (unverified)
Shilpa Medicare Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Happy Forgings Limited
Metal Fabrication · Industrials
Earnings Call
Shilpa Medicare Limited
Earnings Call for the Quarter Ended June 30, 2026
Happy Forgings Limited
Earnings Call
Shilpa Medicare Limited
